1. Home
  2. APEI vs RGNX Comparison

APEI vs RGNX Comparison

Compare APEI & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APEI
  • RGNX
  • Stock Information
  • Founded
  • APEI 1991
  • RGNX 2008
  • Country
  • APEI United States
  • RGNX United States
  • Employees
  • APEI N/A
  • RGNX N/A
  • Industry
  • APEI Other Consumer Services
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • APEI Consumer Discretionary
  • RGNX Health Care
  • Exchange
  • APEI Nasdaq
  • RGNX Nasdaq
  • Market Cap
  • APEI 453.1M
  • RGNX 387.0M
  • IPO Year
  • APEI 2007
  • RGNX 2015
  • Fundamental
  • Price
  • APEI $29.78
  • RGNX $8.89
  • Analyst Decision
  • APEI Strong Buy
  • RGNX Strong Buy
  • Analyst Count
  • APEI 5
  • RGNX 8
  • Target Price
  • APEI $30.50
  • RGNX $31.75
  • AVG Volume (30 Days)
  • APEI 251.8K
  • RGNX 1.2M
  • Earning Date
  • APEI 05-12-2025
  • RGNX 05-12-2025
  • Dividend Yield
  • APEI N/A
  • RGNX N/A
  • EPS Growth
  • APEI N/A
  • RGNX N/A
  • EPS
  • APEI 1.02
  • RGNX N/A
  • Revenue
  • APEI $634,678,000.00
  • RGNX $156,718,000.00
  • Revenue This Year
  • APEI $7.12
  • RGNX $313.52
  • Revenue Next Year
  • APEI $4.17
  • RGNX N/A
  • P/E Ratio
  • APEI $28.84
  • RGNX N/A
  • Revenue Growth
  • APEI 4.86
  • RGNX 80.70
  • 52 Week Low
  • APEI $11.80
  • RGNX $5.04
  • 52 Week High
  • APEI $30.09
  • RGNX $15.91
  • Technical
  • Relative Strength Index (RSI)
  • APEI 68.56
  • RGNX 59.24
  • Support Level
  • APEI $27.90
  • RGNX $9.40
  • Resistance Level
  • APEI $29.74
  • RGNX $10.44
  • Average True Range (ATR)
  • APEI 1.57
  • RGNX 0.76
  • MACD
  • APEI 0.18
  • RGNX 0.08
  • Stochastic Oscillator
  • APEI 91.89
  • RGNX 76.06

About APEI American Public Education Inc.

American Public Education Inc provides online and campus based postsecondary education including various undergraduate and graduate degree programs. The fields of study include business administration, health science, technology, criminal justice, education, liberal arts, national security, military studies, intelligence, and homeland security. There are three reporting segments: the American Public University segment which is the key revenue generator; the Rasmussen University Segment and the Hondros College of Nursing segment. The revenue is generated from net course registrations and enrollment, tuition rate, net tuition, and other fees.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

Share on Social Networks: